Brian Stemme
@brianstemme
ID: 983779716
02-12-2012 03:09:17
1,1K Tweet
145 Takipçi
81 Takip Edilen
Former HCRN Chief Scientific Officer, Shadia Jalal, MD of IU Simon Comprehensive Cancer Center, gives her perspective on how the current shortage of certain cancer drugs can effect clinical trials 👇
CEO @brianstemme joins Tom Jensen who represents the Kenneth and Verna Mae Jessen award, which was first presented in 2022 to IU Simon Comprehensive Cancer Center Ed Greenfield for work on osteosarcoma
.@HoosierCancer recently launched a #Sarcoma Clinical Trial Working Group, led by (from left) Atrayee Basu Mallick of Jefferson Health, Mark Agulnik, MD of City of Hope, and Kristen Ganjoo of Stanford Medicine. Learn more about our co-chairs and their shared vision and goals: hoosiercancer.org/hcrn-sarcoma-c…
BREAKING NEWS: For the first time, Butler Basketball is putting an alumni team in TBT! (𝘈𝘭𝘭 𝘎𝘰𝘰𝘥 𝘋𝘢𝘸𝘨𝘴) Oh yeah… THEY’RE ALSO HOSTING A REGIONAL AT 𝐇𝐈𝐍𝐊𝐋𝐄 𝐅𝐈𝐄𝐋𝐃𝐇𝐎𝐔𝐒𝐄🤯 (July 19-24) 🎟️Ticket Waitlist for All Good Dawgs - Butler’s TBT Team: thetournament.com/tbt/tickets/
Eric Singhi (Eric K. Singhi, MD) of MD Anderson Cancer Center shared a presentation, “Navigating the Research Playbook: Strategies for Patient-Clinician Communication in Clinical Trials," covering the landscape, importance, challenges, & future direction of lung cancer research. #EndLungCancerNow
A helpful peek 🔍 at the #operations related to overcoming key 🔑 barriers to conducting clinical #trials for patient research in #lungcancer from Hoosier Cancer CEO Brian Stemme @ #EndLungCancerNow gathering. #LCAM #LCSM SmallCellSMASHERS Nasser Hanna Eric K. Singhi, MD Jill Feldman